Coronavirus Disease 2019 (COVID‐19) Pandemic Implications in Pediatric and Adult Congenital Heart Disease
Top Cited Papers
Open Access
- 16 June 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Heart Association
- Vol. 9 (12), e017224
- https://doi.org/10.1161/jaha.120.017224
Abstract
The corona virus disease ‐2019 (COVID‐19) is a recently described infectious disease caused by the severe acute respiratory syndrome corona virus 2 with significant cardiovascular implications. Given the increased risk for severe COVID‐19 observed in adults with underlying cardiac involvement, there is concern that patients with pediatric and congenital heart disease (CHD) may likewise be at increased risk for severe infection. The cardiac manifestations of COVID‐19 include myocarditis, arrhythmia and myocardial infarction. Importantly, the pandemic has stretched health care systems and many care team members are at risk for contracting and possibly transmitting the disease which may further impact the care of patients with cardiovascular disease. In this review, we describe the effects of COVID‐19 in the pediatric and young adult population and review the cardiovascular involvement in COVID‐19 focusing on implications for patients with congenital heart disease in particular.This publication has 58 references indexed in Scilit:
- Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus InfectionPEDIATRICS, 2014
- Endocarditis in Congenital Heart DiseaseCirculation, 2013
- Anti-platelet agents in pediatric cardiac practiceAnnals of Pediatric Cardiology, 2013
- Electrophysiology and Adult Congenital Heart Disease: Advances and OptionsProgress in Cardiovascular Diseases, 2011
- ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway EpitheliaJournal of Virology, 2005
- Good ACE, bad ACE do battle in lung injury, SARSNature Medicine, 2005
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Reye's syndrome developing in an infant on treatment of Kawasaki syndromeJournal of Paediatrics and Child Health, 2005
- Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS‐CoV) and its putative receptor, angiotensin‐converting enzyme 2 (ACE2)The Journal of Pathology, 2004
- The Total Correction of Congenital Heart Disease in InfantsAnnual Review of Medicine, 1975